BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9590191)

  • 1. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis.
    Nishimura M; Takahashi H; Maruyama K; Ohtsuka K; Nanbu A; Hara K; Yoshimura M
    Am J Kidney Dis; 1998 May; 31(5):809-17. PubMed ID: 9590191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide in haemodialysis hypotension.
    Nishimura M; Takahashi H; Yoshimura M
    Acta Physiol Scand; 2000 Jan; 168(1):181-6. PubMed ID: 10691798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.
    Raj DS; Vincent B; Simpson K; Sato E; Jones KL; Welbourne TC; Levi M; Shah V; Blandon P; Zager P; Robbins RA
    Kidney Int; 2002 Feb; 61(2):697-704. PubMed ID: 11849413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nitric oxide production in patients with hypotension during hemodialysis.
    Yokokawa K; Mankus R; Saklayen MG; Kohno M; Yasunari K; Minami M; Kano H; Horio T; Takeda T; Mandel AK
    Ann Intern Med; 1995 Jul; 123(1):35-7. PubMed ID: 7762912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotension during hemodialysis: role for nitric oxide.
    Kang ES; Acchiardo SR; Wang YB; Tevlin MT; Hughes T; Cardoso S
    Am J Med Sci; 1997 Mar; 313(3):138-46. PubMed ID: 9075430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased nitric oxide production in hypotensive hemodialysis patients.
    Lin SH; Chu P; Yu FC; Diang LK; Lin YF
    ASAIO J; 1996; 42(5):M895-9. PubMed ID: 8945014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of human hepatocyte growth factor with hemodialysis hypotension.
    Nishimura M; Ushiyama M; Maruyama Y; Mabuchi H; Takahashi H; Yoshimura M
    Hypertens Res; 2000 Nov; 23(6):581-6. PubMed ID: 11131269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of blood pressure variability in patients with chronic renal failure under maintenance hemodialysis].
    Takahashi H; Masaki H; Nishimura M
    Rinsho Byori; 2001 Mar; 49(3):239-43. PubMed ID: 11307322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma adrenomedullin levels in hemodialysis patients with sustained hypotension.
    Cases A; Esforzado N; Lario S; Vera M; Lopez-Pedret J; Rivera-Fillat F; Jimenez W
    Kidney Int; 2000 Feb; 57(2):664-70. PubMed ID: 10652045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability.
    Pelosi G; Emdin M; Carpeggiani C; Morales MA; Piacenti M; Dattolo P; Cerrai T; Macerata A; L'abbate A; Maggiore Q
    Clin Sci (Lond); 1999 Jan; 96(1):23-31. PubMed ID: 9857103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure.
    Matsumoto A; Hirata Y; Kakoki M; Nagata D; Momomura Si; Sugimoto T; Tagawa H; Omata M
    Clin Sci (Lond); 1999 Jan; 96(1):67-74. PubMed ID: 9857108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension.
    Peer G; Itzhakov E; Wollman Y; Chernihovsky T; Grosskopf I; Segev D; Silverberg D; Blum M; Schwartz D; Iaina A
    Nephrol Dial Transplant; 2001 Jul; 16(7):1436-41. PubMed ID: 11427637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible sequestration of nitric oxide by hemoglobin during hemodialysis in end-stage renal disease.
    Kang ES; Miles DE; Tevlin MT; Cates TB; Acchiardo SR
    Am J Med Sci; 2001 Feb; 321(2):113-23. PubMed ID: 11217813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baroreflex sensitivity and sympatho-vagal balance during intradialytic hypotensive episodes.
    Sapoznikov D; Backenroth R; Rubinger D
    J Hypertens; 2010 Feb; 28(2):314-24. PubMed ID: 19927010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period.
    Kang ES; Tevlin MT; Wang YB; Chiang TM; Cardenas R; Myers LK; Acchiardo SR
    Am J Med Sci; 1999 Jan; 317(1):9-21. PubMed ID: 9892267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and sympathetic nerve tone relation during hemodialysis may reflect cardiovascular dysfunction.
    Ino-Oka E; Urae J; Sekino M; Satoh M; Takeuchi K; Sekino H; Ohtaki Y; Inooka H
    Intern Med; 2011; 50(22):2741-8. PubMed ID: 22082885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients.
    Chang YM; Shiao CC; Chang KC; Chen IL; Yang CL; Leu SC; Su HL; Kao JL; Tsai SC; Jhen RN
    Clin Exp Nephrol; 2016 Aug; 20(4):650-659. PubMed ID: 26511876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hypotension in hemodialysis patients: role of functional vascular changes and vasodilator agents.
    Coll E; Larrousse M; de la Sierra A; Collado S; Jiménez W; Cases A
    Clin Nephrol; 2008 Feb; 69(2):114-20. PubMed ID: 18365352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide in hypotension during hemodialysis.
    Nakayama M; Kawaguchi Y; Numata M; Hasegawa T; Hosoya T
    Nephron; 1998 Aug; 79(4):490-1. PubMed ID: 9689175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.